stock at ATH 381
Posts in category All News
Broker’s call: Saregama (Buy) (07-11-2024)
Emkay Global
Decision Day Guide: US Fed set to cut rates again as post-election uncertainty grows (07-11-2024)
The Fed has long guarded its status as an independent institution able to make difficult decisions about borrowing rates, free from political interference. Yet during his previous term in the White House, Trump publicly attacked Chair Jerome Powell after the Fed raised rates to fight inflation, and he may do so again.
Jagsonpal Pharma has investments by Mukul Agrawal, Lincoln Coelho & Sanjay Dangi (07-11-2024)
Jagsonpal Pharma has investments by Mukul Agrawal (₹28 Cr), Lincoln Coelho (₹19 Cr) & Sanjay Dangi (Authum) (₹23 Cr). M-Cap is ₹1600 Cr. Promoters hold 68%. Co is Debt-Free. RoCE is 18%. It has a portfolio of drugs focusing on Gynecology & Orthopedic with many leading brands
Could Trump’s Tariffs Lead to Higher Prices? Here’s What to Know. (07-11-2024)
The president-elect says that tariff is “the most beautiful word in the dictionary.” You may be hearing it a lot.
SEBI to consider demerger of equity exchanges, clearing corporations (07-11-2024)
Aims for diversified ownership, enhanced supervision, and independence
Aptus has significant headroom for growth due to housing shortage (07-11-2024)
Aptus has significant headroom for growth due to housing shortage in tier II – IV cities & Govt initiatives. Co is confident of strong AUM growth & stable asset quality. Its core strengths & prudent underwriting practice provide comfort. TP ₹425 (25%)
Aptus has significant headroom for growth due to housing shortage
US stocks extend rally from Trump victory, ahead of Fed rate decision (07-11-2024)
Wall Street’s main stock indexes hit record highs in the run-up to an interest-rate decision from the Federal Reserve on Thursday, extending a sharp rally sparked by Donald Trump’s stunning comeback as U.S. president for a second time.